Live Breaking News & Updates on தலை ஆஃப் தடுப்பூசி ஒழுங்குமுறை வளர்ச்சி

Stay updated with breaking news from தலை ஆஃப் தடுப்பூசி ஒழுங்குமுறை வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Novavax, Inc.January 15, 2021 GMT
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global regulatory strategy and execution as well as the quality assurance function for the company’s development-stage vaccine candidates, including its recombinant protein-based COVID-19 candidate vaccine, NVX-CoV2373. ....

Baptist Hospital , United States , Vanderbilt University , Edna Kaplan , Henrietta Ukwu , Stanleyc Erck , Erika Trahan , Merck Co Inc , Head Of Global Regulatory Affairs , Novavax Inc , University Of Jos School Medicine , Otsuka Pharmaceuticals , Regulatory Affairs , Head Of Vaccine Regulatory Development , Wyeth Pharmaceuticals Inc , American College Of Physicians , Exchange Commission , Global Regulatory Affairs , Regulatory Affairs Professional Society , Senior Vice President , Chief Regulatory , Chief Executive Officer , Chief Regulatory Officer , Global Head , Wyeth Pharmaceuticals , Vice President ,

Novavax, Inc.: Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer


Novavax, Inc.: Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global regulatory strategy and execution as well as the quality assurance function for the company s development-stage vaccine candidates, including its recombinant protein-based COVID-19 candidate vaccine, NVX-CoV2373.
Dr. Ukwu brings extensive regulatory affairs and quality expertise and leadership experience at precisely the right time for Novavax, as we advance toward data readouts and regulatory submissions in 2021, said Stanley C. Erck, President and Chief Executive Officer, Novav ....

Baptist Hospital , United States , Vanderbilt University , Twitterand Linkedin , Henrietta Ukwu , Stanleyc Erck , Otsuka Pharmaceuticals , Regulatory Affairs , Head Of Vaccine Regulatory Development , Wyeth Pharmaceuticals Inc , Merck Co Inc , Exchange Commission , American College Of Physicians , Head Of Global Regulatory Affairs , Global Regulatory Affairs , Novavax Inc , Regulatory Affairs Professional Society , University Of Jos School Medicine , Senior Vice President , Chief Regulatory , Chief Executive Officer , Chief Regulatory Officer , Global Head , Wyeth Pharmaceuticals , Vice President , Vaccine Regulatory Development ,

Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer | Comunicados | Edición USA


15 ene 2021
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global regulatory strategy and execution as well as the quality assurance function for the company’s development-stage vaccine candidates, including its recombinant protein-based COVID-19 candidate vaccine, NVX-CoV2373.
“Dr. Ukwu brings extensive regulatory affairs and quality expertise and leadership experience at precisely the right time for Novavax, as we advance toward data readouts and regulatory submissions in 2021,” said Stanley C. Erck, President and Chief Executive Office ....

Baptist Hospital , United States , Vanderbilt University , Edna Kaplan , Henrietta Ukwu , Stanleyc Erck , Erika Trahan , Merck Co Inc , Head Of Global Regulatory Affairs , Novavax Inc , University Of Jos School Medicine , Otsuka Pharmaceuticals , Regulatory Affairs , Head Of Vaccine Regulatory Development , Wyeth Pharmaceuticals Inc , American College Of Physicians , Exchange Commission , Global Regulatory Affairs , Regulatory Affairs Professional Society , Regulatory Expert Henrietta Ukwu , Chief Regulatory , Senior Vice President , Chief Executive Officer , Chief Regulatory Officer , Global Head , Wyeth Pharmaceuticals ,

Investegate |Novavax, Inc. Announcements | Novavax, Inc.: Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer


Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global regulatory strategy and execution as well as the quality assurance function for the company’s development-stage vaccine candidates, including its recombinant protein-based COVID-19 candidate vaccine, NVX-CoV2373.
“Dr. Ukwu brings extensive regulatory affairs and quality expertise and leadership experience at precisely the right time for Novavax, as we advance toward data readouts and regulatory submissions in 2021,” said Stanley C. Erck, President and Chief Executive Officer, Novavax. “W ....

Baptist Hospital , United States , Vanderbilt University , Henrietta Ukwu , Stanleyc Erck , Merck Co Inc , Head Of Global Regulatory Affairs , Novavax Inc , University Of Jos School Medicine , Otsuka Pharmaceuticals , Regulatory Affairs , Head Of Vaccine Regulatory Development , Wyeth Pharmaceuticals Inc , American College Of Physicians , Global Regulatory Affairs , Regulatory Affairs Professional Society , Regulatory Expert Henrietta Ukwu , Chief Regulatory , Senior Vice President , Chief Executive Officer , Chief Regulatory Officer , Global Head , Wyeth Pharmaceuticals , Vice President , Vaccine Regulatory Development , Global Regulatory ,